VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISHL HL Update 2021 | Response biomarkers in HL

Sven Borchmann, MD, University of Cologne, Cologne, Germany, discusses the genetics of classical Hodgkin lymphoma (HL) and the use of biomarkers as a response marker, as discussed at the virtual Update on Hodgkin Lymphoma organized by the International Symposium on Hodgkin Lymphoma (ISHL). Dr Borchmann highlights the potential of circulating tumor DNA and protein-based biomarkers that can be used alongside PET imaging to determine a patient’s response to treatment in clinical practice and trial settings. This interview took place at the Update on Hodgkin Lymphoma 2021, a Virtual ISHL event.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter